Tuberculosis Trial, Recruiting NCT04271397 Sponsor: Hospices Civils de Lyon Condition: Tuberculosis
Back to Tuberculosis

Tuberculosis Trial, Recruiting

NCT04271397
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older
  • People who have given written agreement to take part in the trial
  • People who are willing to attend follow-up appointments for at least 6 months
  • People with confirmed active tuberculosis (TB), shown through a positive lab test and/or a positive PCR test
  • People with latent TB infection (TB present in the body but not causing active illness), confirmed by a positive IGRA blood test

Who may not be able to join:

  • People who have a solid cancerous tumour
  • People who have a blood cancer or other cancer of the blood or lymph system
  • People who have received a transplanted organ or a bone marrow/stem cell transplant
  • People who are taking medications that suppress the immune system (such as biologics, calcineurin inhibitors, or corticosteroids)
  • People who have an auto-inflammatory disease (a condition where the immune system causes ongoing inflammation) (confirm with trial site)
  • People who have a chronic liver disease
  • People living with HIV, hepatitis C, or hepatitis B
  • People who have already been taking anti-TB medications for more than 7 days
  • People who are pregnant or breastfeeding
  • People who do not wish to participate
  • People whose freedom is restricted by a legal or government decision
  • Adults who are under legal protection or guardianship
  • People who are not covered by a social security health scheme
  • People who are experiencing homelessness

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 04 72 07 11 07

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
30 September 2019
Est. completion
10 September 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Concordance of the kinetics of biomarkers with the evolution of the disease

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov